Cytokinetics, Incorporated
Stock Details
Is it expensive?
Trailing P/E Ratio
-12.53
Forward P/E Ratio
-17.44
PEG Ratio
-0.55
-17.26
Price-to-Sales (TTM)
104.53
-12.22
-6.65
Market Cap
11.12B
10.86B
Is it profitable?
Net Profit Margin (TTM)
-372.55%
Gross Profit Margin
86.81%
Diluted EPS (TTM)
-6.85
119.00%
105.82M
Is it growing?
1,125.80%
1,125.78%
Is it risky?
0.42
-1.75
4.21
1.44B
Who owns it?
118.74%
0.67%
20.01%
124.24M
123.87M
Does it pay?
0.00%
0.00%
--
--
How much cash?
818.55M
-523.85M
-381.06M
6.58
- Price
- 81.93
- Percent Change
- -0.31 (0.38%)
- Previous Close
- 82.24
- Open
- 82.88
- Low
- 80.61
- High
- 83.06
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$81.93
From 52W Low
+149.10%
From 52W High
-7.22%
Today
-0.38%
1Y Change
+115.55%
6M
$63.44
3M
$65.37
1M
$71.38
Today
$81.93
From 52W Low
+149.10%
From 52W High
-7.22%
Today
-0.38%
1Y Change
+115.55%
6M
$63.44
3M
$65.37
1M
$71.38
Today
$81.93
Expensive
within its 1-year price range
$81.93
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+14.8%
3M
+25.3%
6M
+29.1%
1Y
+115.5%
Rate of Change (ROC)
Accelerating
Price is rising 1.9x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Cytokinetics, Incorporated
- Founded
- 1997
- CEO
- Robert I. Blum
- Employees
- 673
- Fiscal Year End
- Dec 31, 2025
- Address
350 Oyster Point Boulevard
South San Francisco
California
94080
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.cytokinetics.com
Indicators
Operating Cash Flow
-523.85M
Net Income
-829.61M
Mixed Signal
0.63
Cash flow is meaningfully below reported profit. Some gap is normal, but a persistent gap warrants questioning of the accounting.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Indicators
Operating Cash Flow
-523.85M
Net Income
-829.61M
Mixed Signal
0.63
Cash flow is meaningfully below reported profit. Some gap is normal, but a persistent gap warrants questioning of the accounting.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
-12.53
Forward P/E Ratio
-17.44
PEG Ratio
-0.55
-17.26
Price-to-Sales (TTM)
104.53
-12.22
-6.65
Market Cap
11.12B
10.86B
Is it profitable?
Net Profit Margin (TTM)
-372.55%
Gross Profit Margin
86.81%
Diluted EPS (TTM)
-6.85
119.00%
105.82M
Is it growing?
1,125.80%
1,125.78%
Is it risky?
0.42
-1.75
4.21
1.44B
Who owns it?
118.74%
0.67%
20.01%
124.24M
123.87M
Does it pay?
0.00%
0.00%
--
--
How much cash?
818.55M
-523.85M
-381.06M
6.58
- Price
- 81.93
- Percent Change
- -0.31 (0.38%)
- Previous Close
- 82.24
- Open
- 82.88
- Low
- 80.61
- High
- 83.06
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$81.93
From 52W Low
+149.10%
From 52W High
-7.22%
Today
-0.38%
1Y Change
+115.55%
6M
$63.44
3M
$65.37
1M
$71.38
Today
$81.93
From 52W Low
+149.10%
From 52W High
-7.22%
Today
-0.38%
1Y Change
+115.55%
6M
$63.44
3M
$65.37
1M
$71.38
Today
$81.93
Expensive
within its 1-year price range
$81.93
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+14.8%
3M
+25.3%
6M
+29.1%
1Y
+115.5%
Rate of Change (ROC)
Accelerating
Price is rising 1.9x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Cytokinetics, Incorporated
- Founded
- 1997
- CEO
- Robert I. Blum
- Employees
- 673
- Fiscal Year End
- Dec 31, 2025
- Address
350 Oyster Point Boulevard
South San Francisco
California
94080
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.cytokinetics.com